During the last session, Citius Oncology Inc (NASDAQ:CTOR)’s traded shares were 1.23 million, with the beta value of the company hitting -0.19. At the end of the trading day, the stock’s price was $0.64, reflecting an intraday loss of -19.40% or -$0.15. The 52-week high for the CTOR share is $49.00, that puts it down -7556.25 from that peak though still a striking 14.06% gain since the share price plummeted to a 52-week low of $0.55. The company’s market capitalization is $45.79M, and the average intraday trading volume over the past 10 days was 0.13 million shares, and the average trade volume was 103.88K shares over the past three months.
Citius Oncology Inc (NASDAQ:CTOR) trade information
Citius Oncology Inc (CTOR) registered a -19.40% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -19.40% in intraday trading to $0.64, hitting a weekly high. The stock’s 5-day price performance is 2.73%, and it has moved by -46.22% in 30 days. Based on these gigs, the overall price performance for the year is -94.14%. The short interest in Citius Oncology Inc (NASDAQ:CTOR) is 27881.0 shares and it means that shorts have 0.54 day(s) to cover.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 5.74M as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 8.6M by the end of current fiscal year.
CTOR Dividends
Citius Oncology Inc is due to release its next quarterly earnings on 2025-Feb-13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Citius Oncology Inc (NASDAQ:CTOR)’s Major holders
Citius Oncology Inc insiders own 95.08% of total outstanding shares while institutional holders control 0.89%, with the float percentage being 18.10%.
Data provided on Dec 31, 2024 indicates that Fidelity Nasdaq Composite Index Fund owns about 12.65 shares. This amounts to just over 0.02 percent of the company’s overall shares, with a $8096.0 market value.
